FDA wants feedback on how to regulate generative AI in medicine
“Generative AI-enabled medical devices are poised to reshape the health technology landscape, and the FDA has an important responsibility to provide thoughtful leadership for this new era,” says radiologist Rick Abramson, MD.
“Generative AI-enabled medical devices are poised to reshape the health technology landscape, and the FDA has an important responsibility to provide thoughtful leadership for this new era,” says radiologist Rick Abramson, MD.
What's Your Reaction?
